The 17th Advancing Women’s Leadership in Pharma & Healthcare Conference is set to take place on August 27–28, 2026, at the Sonesta Philadelphia Rittenhouse Hotel in Philadelphia, Pennsylvania. Organized by Dynamic Global Events (DGE), the conference aims to empower women and allies across the pharmaceutical, biotechnology, healthcare, and life sciences industries.
Industry leaders will share insights on mentorship and leadership development, fostering a collaborative forum where emerging and established professionals can exchange ideas, build connections, and gain valuable knowledge. The event is designed to address the ongoing need for gender diversity and leadership parity in these critical sectors.
This conference matters because the pharmaceutical and healthcare industries continue to face gender gaps in executive and leadership roles. By bringing together thought leaders and practitioners, the event provides a platform for actionable strategies to advance women’s careers. Attendees can expect to learn about overcoming barriers, building effective networks, and leveraging mentorship opportunities.
The implications for the industry are significant. As healthcare and pharma companies strive for innovation and better patient outcomes, diverse leadership teams have been shown to drive better decision-making and financial performance. Conferences like this help to accelerate progress by equipping women with the tools and connections needed to ascend to leadership positions.
For more information about the conference, visit https://ibn.fm/3s99n.
InvestorWire (IW), a specialized communications platform focused on wire-grade press release syndication, is covering the event. IW is part of the Dynamic Brand Portfolio @IBN, which delivers access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release services, social media distribution, and tailored corporate communications solutions. For more about InvestorWire, visit https://www.InvestorWire.com. Full terms and disclaimers are available at https://www.InvestorWire.com/Disclaimer.
InvestorWire is based in Austin, Texas, and can be reached at 512.354.7000. It is powered by IBN.
